bioCSL has commenced distribution of Immucor’s Capture technology platform and reagents in Australia and New Zealand. Capture is antibody detection technology used in the crossmatching of blood used for transfusion.
The technology is said to work differently from the techniques commonly used in Australia, delivering high levels of specificity and potentially reducing both the need for additional testing and delays for patients awaiting a blood transfusion. The product has a high degree of sensitivity for detection of clinically significant antibodies, providing confidence and accuracy in pre‐transfusion and prenatal screening.
Phone: 1300 369 559
Antibodies.com neutrophil marker antibodies
Antibodies.com offers a variety of markers that identify neutrophils at various stages of...
TRC stable isotope labelled (SIL) compounds
TRC's high-quality stable isotope labelled (SIL) compounds are important tools for...
Cayman Chemical Prostaglandin Screening Library I (96-Well)
The Prostaglandin Screening Library I from Cayman Chemical is intended for the screening of PGF...
